The FDA Group's Insider Newsletter

The FDA Group's Insider Newsletter

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
Small Lots, Big Risks: Rethinking Statistical Sampling in Biopharma
Copy link
Facebook
Email
Notes
More

Small Lots, Big Risks: Rethinking Statistical…

The FDA Group
Aug 29, 2024
2

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
Small Lots, Big Risks: Rethinking Statistical Sampling in Biopharma
Copy link
Facebook
Email
Notes
More

Watch now (19 mins) | We sat down with Gary Ritchie to learn why N + 1 doesn't always add up.

Read →
Comments
User's avatar
© 2025 The FDA Group, LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More